Surface-Modified Metal Particles in Biodegradable Polymer Implants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Biodegradable polymers used in biomedical implants generate acidic byproducts during degradation, leading to inflammation and cytotoxicity, and existing methods to suppress inflammation often involve anti-inflammatory drugs with potential side effects, while lacking a solution for neutralizing these acidic byproducts and improving the physical properties of these polymers.
Innovation Solution
Surface-modified basic metal particles, such as alkali and alkaline earth metals, are combined with biodegradable polymers to neutralize acidic byproducts and enhance the physical and mechanical properties of the polymers, thereby reducing inflammation and cytotoxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If biodegradable polymers are used in biomedical implants, then they are completely degraded after a certain period minimizing foreign body reaction, but acidic byproducts are generated causing inflammation reactions and cytotoxicity
Solution Approach 1:
Basic metal particles (calcium, magnesium, or zinc) are introduced as intermediary substances that chemically neutralize the acidic byproducts generated during polymer degradation. These metal particles act as a buffer system, accepting protons from lactic acid and glycolic acid to form water and soluble salts, thereby eliminating the harmful acidic environment while the metals themselves are biocompatible and gradually absorbed
Solution Approach 2:
The patent creates a composite material system combining biodegradable polymer matrices with basic metal particles. This composite approach allows the polymer to provide structural functionality and gradual degradation while the embedded basic metal particles simultaneously neutralize acidic byproducts, achieving both mechanical support and pH regulation in a single integrated implant material
2Object-generated harmful factors
If anti-inflammatory drugs are contained in biomaterials to suppress inflammation, then inflammation reactions are suppressed, but side effects occur due to drug use
Solution Approach 1:
The patent replaces the chemical/pharmacological approach (using anti-inflammatory drugs) with a physical/chemical buffering approach (using basic metal particles). Instead of introducing exogenous chemical agents that may cause side effects, the system uses inorganic metal bases that provide passive chemical buffering through simple acid-base neutralization reactions, eliminating drug-related side effects while still suppressing inflammation caused by acidic byproducts
3Reliability
If the surface of basic metal particles is modified with polymer, then compatibility with biodegradable polymers is improved and basic characteristics are controlled, but additional processing steps are required
Solution Approach 1:
A thin polymer coating layer is applied to the surface of basic metal particles, creating a flexible interface between the inorganic metal core and the organic polymer matrix. This thin film shell serves multiple functions: it improves interfacial compatibility and adhesion, prevents excessive localized basicity, and facilitates uniform dispersion of metal particles within the polymer matrix, while the simplicity of the coating process keeps manufacturing complexity manageable
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination of surface-modified metal particles with biodegradable polymers effectively neutralizes acidic byproducts, suppressing inflammation and improving the mechanical properties of biomedical implants, making them suitable for various medical applications without the side effects associated with drug-based solutions.
Implementation Method 1
basic metal particles of which surface are modified with a polymer and a biodegradable polymer... neutralizing the acidic byproducts with a basic metal
Data Source
AI summary
Disclosed are biomedical implants comprising surface-modified metal particles and biodegradable polymers; its use for suppressing inflammation; and a method for preparing a biomedical material, comprising: (a) modifying surface of basic metal particles with a polymer to obtain surface-modified metal particles; and (b) mixing the surface-modified metal particles with a biodegradable polymer, followed by manufacturing a biodegradable biomedical implant, or coating the resulting mixture on a conventional biomedical implant.